These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 817791)

  • 1. Waldenström's macroglobulinemia: review of 45 cases.
    Krajny M; Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):899-900, 902, 905. PubMed ID: 817791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit.
    Kyrtsonis MC; Vassilakopoulos TP; Angelopoulou MK; Siakantaris P; Kontopidou FN; Dimopoulou MN; Boussiotis V; Gribabis A; Konstantopoulos K; Vaiopoulos GA; Fessas P; Kittas C; Pangalis GA
    Ann Hematol; 2001 Dec; 80(12):722-7. PubMed ID: 11797112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical studies in a patient with Waldenstrom's macroglobulinemia.
    Mir-Ahmadian M; Rahbar S; Heidery H; Hajaliloo G
    Acta Med Iran; 1978; 21(1):39-46. PubMed ID: 110036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell malignant lymphoma associated with monoclonal macroglobulinemia and cryoglobulinemia.
    Nozaki H; Tanaka K; Shimizu M; Komatsuda M; Tsutsumi Y; Arimori S
    Tokai J Exp Clin Med; 1988 Dec; 13(4-5):245-51. PubMed ID: 3151523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective treatment with rituximab in two patients with Waldenström macroglobulinemia].
    Yoshimi A; Arai S; Iijima K; Iki S; Usuki K; Urabe A
    Rinsho Ketsueki; 2005 Oct; 46(10):1109-13. PubMed ID: 16440772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
    Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IgM myeloma].
    Roujeau JC; Bisson M; Segond P; Massias P
    Sem Hop; 1976 Nov; 52(40):2277-82. PubMed ID: 188179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia.
    Treon SP; Agus TB; Link B; Rodrigues G; Molina A; Lacy MQ; Fisher DC; Emmanouilides C; Richards AI; Clark B; Lucas MS; Schlossman R; Schenkein D; Lin B; Kimby E; Anderson KC; Byrd JC
    J Immunother; 2001; 24(3):272-9. PubMed ID: 11394506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic spectrum of Waldenström's macroglobulinemia: a single center experience.
    Sajid R; Siddiqui SH; Shaikh U; Adil S
    Indian J Pathol Microbiol; 2010; 53(3):490-3. PubMed ID: 20699509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waldenström's macroglobulinemia: a clinicopathologic study of 22 cases.
    Andriko JA; Aguilera NS; Chu WS; Nandedkar MA; Cotelingam JD
    Cancer; 1997 Nov; 80(10):1926-35. PubMed ID: 9366295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.
    Pangalis GA; Kyrtsonis MC; Kontopidou FN; Vassilakopoulos TP; Siakantaris MP; Dimopoulou MN; Kittas C; Angelopoulou MK
    Semin Oncol; 2003 Apr; 30(2):201-5. PubMed ID: 12720136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal gammapathies. (Critical review of 219 cases collected over 3 years)].
    Youinou P; Le Goff P; Saleun JP; Jouquan J; Tymen G; Le Menn G
    Pathol Biol (Paris); 1977 Oct; 25(8):517-21. PubMed ID: 413086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow.
    Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E
    Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of pulmonary Waldenstrom's macroglobulinemia].
    Nii Y; Ogushi F; Satou K; Sone S; Ozaki T; Kobayashi H; Yasuoka S; Ogura T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Jun; 26(6):670-3. PubMed ID: 3149384
    [No Abstract]   [Full Text] [Related]  

  • 16. M components-a review of 1242 cases.
    Ameis A; Ko HS; Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):889-92, 895. PubMed ID: 817789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
    Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Waldenström's macroglobulinemia].
    Tsuruoka N
    Nihon Rinsho; 1995 Mar; 53(3):725-9. PubMed ID: 7699913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of immunoblastic sarcoma in Waldenstrom's macroglobulinemia.
    Leonhard SA; Muhleman AF; Hurtubise PE; Martelo OJ
    Cancer; 1980 Jun; 45(12):3102-7. PubMed ID: 6770989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.